BPO bioprospect limited

trail update

  1. 396 Posts.
    lightbulb Created with Sketch. 37
    AP778 impregnation field trial update.
    BioProspect Limited (ASX:BPO) and its independent science team from the
    University of Western Sydney (UWS) has just completed its first interim inspection of
    its large scale field trial using AP778 impregnated timber against termites at
    Narrandera New South Wales.
    The interim inspection of the Narrandera site showed the site remained undisturbed
    and secure with heavy termite activity. The external inspection of the in-ground trial
    showed that AP778 impregnated stakes remained intact and untouched. Both the inground
    and the hutch trials were performing to the research teams expectations. In
    Australia, elevated termite activity occurs seasonally from approximately September
    to May. The company will conduct a full internal inspection of the trial at the end of
    the termite season to assess AP778’s natural termiticide’s impregnation effects
    against termites.
    Ongoing impregnation laboratory tests conducted at the Centre for Horticulture and
    Plant Science (CHAPS) at UWS’s Hawkesbury campus in NSW show that AP778 is
    proving to be an effective barrier to termite attack. Impregnated Eucalyptus regnans
    timber stakes that were placed under significant termite pressure have remained
    untouched by termites for over six months, whereas the untreated control has been
    noticeable attacked.
    Success with hardwood timbers like Eucalyptus regnans is encouraging as hardwood
    timbers are difficult to impregnate compared with softwood timbers like pine. In
    previous laboratory barrier studies, BioProspect had successfully conducted over 216
    barrier trails, showing that AP778 controls and repels termites.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.